This study demonstrates the reduction in autoantibodies, inflammatory biomarkers, and erythrocyte rouleaux formation after extracorporeal apheresis. Possibly an important intervention for patients that are struggling with long COVID for a prolonged period of time and are refractory to other therapies.
Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis | Molecular Psychiatry
https://www.nature.com/articles/s41380-023-02084-1#Abs1
* Identify symptoms associated with Chronic Fatigue Syndrome.
* Understand the link between clinical improvement in Long COVID and reduction in autoantibodies, lipids, and inflammation through therapeutic Aphresis.
* Comprehend the details of a study on Chronic Fatigue Syndrome and post-exertional malaise.
* Recognize parameters collected in pre and post-Aphresis blood assessments.
* Learn the clinical assessment tools, including FACIT-F Questionnaire and visual analog scales.
* Understand the impact of Aphresis on biomarkers, including neurotransmitter autoantibodies, inflammatory factors, rheological factors, and lipid levels.
MD., MSc., MSc., BSc
Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.
Write A New Comment
0 Comments